Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Recommendations for Reporting Low and High Values for Urine Albumin and Total Protein.

Miller WG, Bachmann LM, Fleming JK, Delanghe JR, Parsa A, Narva AS; Laboratory Working Group of the National Kidney Disease Education Program and the IFCC Working Group for Standardization of Albumin in Urine.

Clin Chem. 2019 Feb;65(2):349-350. doi: 10.1373/clinchem.2018.297861. Epub 2018 Nov 20. No abstract available.

PMID:
30459169
2.

Need for a Judicious Use of Nonsteroidal Anti-inflammatory Drugs to Avoid Community-Acquired Acute Kidney Injury.

Pai AB, Divine H, Marciniak M, Morreale A, Saseen JJ, Say K, Segal AR, Norton JM, Narva AS.

Ann Pharmacother. 2019 Jan;53(1):95-100. doi: 10.1177/1060028018789174. Epub 2018 Jul 18.

PMID:
30019916
3.

Personalizing Longitudinal Care Coordination for Patients with Chronic Kidney Disease.

Cullen TA, Kasthurirathne SN, Norton JM, Narva AS.

Stud Health Technol Inform. 2017;245:1354.

PMID:
29295433
4.

Population Health for CKD and Diabetes: Lessons From the Indian Health Service.

Narva A.

Am J Kidney Dis. 2018 Mar;71(3):407-411. doi: 10.1053/j.ajkd.2017.09.017. Epub 2017 Dec 6.

5.

Complementary Initiatives from the NIDDK to Advance Kidney Health.

Norton JM, Ketchum CJ, Narva AS, Star RA, Rodgers GP.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1544-1547. doi: 10.2215/CJN.02120217. Epub 2017 Jul 17. No abstract available.

6.

Managing CKD by Telemedicine: The Zuni Telenephrology Clinic.

Narva AS, Romancito G, Faber T, Steele ME, Kempner KM.

Adv Chronic Kidney Dis. 2017 Jan;24(1):6-11. doi: 10.1053/j.ackd.2016.11.019. Review.

7.

CE: Improving Outcomes for Patients with Chronic Kidney Disease: Part 2.

Norton JM, Newman EP, Romancito G, Mahooty S, Kuracina T, Narva AS.

Am J Nurs. 2017 Mar;117(3):26-35. doi: 10.1097/01.NAJ.0000513259.90613.27. Review.

PMID:
28187016
8.

CE: Improving Outcomes for Patients with Chronic Kidney Disease: Part 1.

Norton JM, Newman EP, Romancito G, Mahooty S, Kuracina T, Narva AS.

Am J Nurs. 2017 Feb;117(2):22-32. doi: 10.1097/01.NAJ.0000512272.33956.8b.

PMID:
28085685
9.

Vital Signs: Decrease in Incidence of Diabetes-Related End-Stage Renal Disease among American Indians/Alaska Natives - United States, 1996-2013.

Bullock A, Burrows NR, Narva AS, Sheff K, Hora I, Lekiachvili A, Cain H, Espey D.

MMWR Morb Mortal Wkly Rep. 2017 Jan 13;66(1):26-32. doi: 10.15585/mmwr.mm6601e1.

10.

A model for improving CKD outcomes.

Narva AS.

JAAPA. 2016 Nov;29(11):14. No abstract available.

PMID:
27741025
11.

Social Determinants of Racial Disparities in CKD.

Norton JM, Moxey-Mims MM, Eggers PW, Narva AS, Star RA, Kimmel PL, Rodgers GP.

J Am Soc Nephrol. 2016 Sep;27(9):2576-95. doi: 10.1681/ASN.2016010027. Epub 2016 May 13. Review.

12.

Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care.

Narva AS, Norton JM, Boulware LE.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):694-703. doi: 10.2215/CJN.07680715. Epub 2015 Nov 4.

13.

Association of Erythropoietin Dose and Route of Administration with Clinical Outcomes for Patients on Hemodialysis in the United States.

Wright DG, Wright EC, Narva AS, Noguchi CT, Eggers PW.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1822-30. doi: 10.2215/CJN.01590215. Epub 2015 Sep 10.

14.

Laboratory Assessment of Diabetic Kidney Disease.

Narva AS, Bilous RW.

Diabetes Spectr. 2015 Aug;28(3):162-6. doi: 10.2337/diaspect.28.3.162.

15.

CKD as a Model for Improving Chronic Disease Care through Electronic Health Records.

Drawz PE, Archdeacon P, McDonald CJ, Powe NR, Smith KA, Norton J, Williams DE, Patel UD, Narva A.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1488-99. doi: 10.2215/CJN.00940115. Epub 2015 Jun 25.

16.

Early chronic kidney disease: diagnosis, management and models of care.

Wouters OJ, O'Donoghue DJ, Ritchie J, Kanavos PG, Narva AS.

Nat Rev Nephrol. 2015 Aug;11(8):491-502. doi: 10.1038/nrneph.2015.85. Epub 2015 Jun 9. Review.

17.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Am J Kidney Dis. 2014 Oct;64(4):510-33. doi: 10.1053/j.ajkd.2014.08.001.

PMID:
25257325
18.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Diabetes Care. 2014 Oct;37(10):2864-83. doi: 10.2337/dc14-1296.

19.

The last mile: translational research to improve CKD outcomes.

Tuot DS, Diamantidis CJ, Corbett CF, Boulware LE, Fox CH, Harwood DH, Star RA, Rys-Sikora KE, Narva A.

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1802-5. doi: 10.2215/CJN.04310514. Epub 2014 Jun 26.

20.

Survival on dialysis among American Indians and Alaska Natives with diabetes in the United States, 1995-2010.

Burrows NR, Cho P, McKeever Bullard K, Narva AS, Eggers PW.

Am J Public Health. 2014 Jun;104 Suppl 3:S490-5. doi: 10.2105/AJPH.2014.301942. Epub 2014 Apr 22.

21.

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E.

JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427. Erratum in: JAMA. 2014 May 7;311(17):1809.

PMID:
24352797
22.

Using digital media to promote kidney disease education.

Goldstein K, Briggs M, Oleynik V, Cullen M, Jones J, Newman E, Narva A.

Adv Chronic Kidney Dis. 2013 Jul;20(4):364-9. doi: 10.1053/j.ackd.2013.04.001. Review.

23.

Albuminuria prevalence in first morning void compared with previous random urine from adults in the National Health and Nutrition Examination Survey, 2009-2010.

Saydah SH, Pavkov ME, Zhang C, Lacher DA, Eberhardt MS, Burrows NR, Narva AS, Eggers PW, Williams DE.

Clin Chem. 2013 Apr;59(4):675-83. doi: 10.1373/clinchem.2012.195644. Epub 2013 Jan 11.

24.

A reference system for urinary albumin: current status.

Lieske JC, Bondar O, Miller WG, Bachmann LM, Narva AS, Itoh Y, Zegers I, Schimmel H, Phinney K, Bunk DM; National Kidney Disease Education Program – IFCC Working Group on Standardization of Albumin in Urine (WG-SAU).

Clin Chem Lab Med. 2013 May;51(5):981-9. doi: 10.1515/cclm-2012-0768.

PMID:
23241608
25.

[The actual issues of measurement and presentation of results of albumin excretion with urine].

Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ, Itoh Y, Lieske JC, Seccombe DW, Jones G, Bunk DM, Curhan GC, Narva AS.

Klin Lab Diagn. 2012 Mar;(3):43-53. Review. Russian. No abstract available.

PMID:
22712293
26.

Decision support and CKD: not there yet.

Narva AS.

Clin J Am Soc Nephrol. 2012 Apr;7(4):525-6. doi: 10.2215/CJN.02140212. Epub 2012 Mar 15. No abstract available.

27.

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.

Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS; Frequent Hemodialysis Network (FHN) Trial Group, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S.

Kidney Int. 2011 Nov;80(10):1080-91. doi: 10.1038/ki.2011.213. Epub 2011 Jul 20.

28.

Monitoring in diabetes self-management: issues and recommendations for improvement.

Stetson B, Schlundt D, Peyrot M, Ciechanowski P, Austin MM, Young-Hyman D, McKoy J, Hall M, Dorsey R, Fitzner K, Quintana M, Narva A, Urbanski P, Homko C, Sherr D.

Popul Health Manag. 2011 Aug;14(4):189-97. doi: 10.1089/pop.2010.0030. Epub 2011 Feb 15.

PMID:
21323462
29.

Toward a more collaborative federal response to chronic kidney disease.

Narva AS, Briggs M, Jordan R, Pavkov ME, Burrows NR, Williams DE.

Adv Chronic Kidney Dis. 2010 May;17(3):282-8. doi: 10.1053/j.ackd.2010.03.006.

30.

Racial and ethnic differences in albuminuria in individuals with estimated GFR greater than 60 mL/min/1.73 m(2): results from the Kidney Early Evaluation Program (KEEP).

Jolly SE, Burrows NR, Chen SC, Li S, Jurkovitz CT, Narva AS, Norris KC, Shlipak MG.

Am J Kidney Dis. 2010 Mar;55(3 Suppl 2):S15-22. doi: 10.1053/j.ajkd.2009.09.034.

31.

[Current issues in measurement and reporting of urinary albumin excretion].

Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ, Itoh Y, Lieske JC, Seccombe DW, Jones G, Bunk DM, Curhan GC, Narva AS; National Kidney Disease Education Program-IFCC Working Group on Standardization of Albumin in Urine.

Ann Biol Clin (Paris). 2010 Jan-Feb;68(1):9-25. doi: 10.1684/abc.2010.0402. French.

32.

Reducing health disparities in American Indians with chronic kidney disease.

Narva AS, Sequist TD.

Semin Nephrol. 2010 Jan;30(1):19-25. doi: 10.1016/j.semnephrol.2009.10.007.

PMID:
20116644
33.

Optimal preparation for ESRD.

Narva AS.

Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S110-3. doi: 10.2215/CJN.03900609. Review.

34.

Assessment of kidney function for drug dosing.

Narva AS.

Clin Chem. 2009 Sep;55(9):1609-11. doi: 10.1373/clinchem.2009.127944. Epub 2009 Jul 9. No abstract available.

35.

Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.

Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Group.

Clin J Am Soc Nephrol. 2009 Aug;4(8):1302-11. doi: 10.2215/CJN.00070109. Epub 2009 Jun 18. Erratum in: Clin J Am Soc Nephrol. 2011 Oct;6(10):2548-53.

36.

The National Kidney Disease Education Program: improving understanding, detection, and management of CKD.

Narva AS, Briggs M.

Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S115-20. doi: 10.1053/j.ajkd.2008.05.038. Erratum in: Am J Kidney Dis. 2009 May;53(5):913.

PMID:
19231755
37.

Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities.

McClellan WM, Satko SG, Gladstone E, Krisher JO, Narva AS, Freedman BI.

Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S100-6. doi: 10.1053/j.ajkd.2008.07.059.

PMID:
19231753
38.

Current issues in measurement and reporting of urinary albumin excretion.

Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ, Itoh Y, Lieske JC, Seccombe DW, Jones G, Bunk DM, Curhan GC, Narva AS; National Kidney Disease Education Program-IFCC Working Group on Standardization of Albumin in Urine.

Clin Chem. 2009 Jan;55(1):24-38. doi: 10.1373/clinchem.2008.106567. Epub 2008 Nov 21. Review.

39.

Risk factors for chronic kidney disease among American Indians and Alaska Natives--findings from the Kidney Early Evaluation Program.

Jolly SE, Li S, Chen SC, Narva AS, Jurkovitz CT, Norris KC, Shlipak MG.

Am J Nephrol. 2009;29(5):440-6. doi: 10.1159/000174857. Epub 2008 Nov 14.

40.

The National Kidney Disease Education Program and other related efforts in the United States.

Narva AS.

Scand J Clin Lab Invest Suppl. 2008;241:12-5. doi: 10.1080/00365510802144870.

PMID:
18569959
41.

Prevalence of estimated GFR reporting among US clinical laboratories.

Accetta NA, Gladstone EH, DiSogra C, Wright EC, Briggs M, Narva AS.

Am J Kidney Dis. 2008 Oct;52(4):778-87. doi: 10.1053/j.ajkd.2008.05.023. Epub 2008 Aug 3.

42.

Reducing the burden of chronic kidney disease among American Indians.

Narva AS.

Adv Chronic Kidney Dis. 2008 Apr;15(2):168-73. doi: 10.1053/j.ackd.2008.01.011.

PMID:
18334242
43.

Clinical challenges in vulnerable CKD populations.

Narva AS, Murray AM, Lane PH.

Adv Chronic Kidney Dis. 2008 Apr;15(2):99-100. doi: 10.1053/j.ackd.2008.01.016. No abstract available.

PMID:
18334232
44.

Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).

Duru OK, Li S, Jurkovitz C, Bakris G, Brown W, Chen SC, Collins A, Klag M, McCullough PA, McGill J, Narva A, Pergola P, Singh A, Norris K.

Am J Kidney Dis. 2008 Feb;51(2):192-8. doi: 10.1053/j.ajkd.2007.09.023.

45.

Low birth weight is associated with chronic kidney disease only in men.

Li S, Chen SC, Shlipak M, Bakris G, McCullough PA, Sowers J, Stevens L, Jurkovitz C, McFarlane S, Norris K, Vassalotti J, Klag MJ, Brown WW, Narva A, Calhoun D, Johnson B, Obialo C, Whaley-Connell A, Becker B, Collins AJ; Kidney Early Evaluation Program Investigators.

Kidney Int. 2008 Mar;73(5):637-42. Epub 2007 Dec 19.

46.

Screening is part of kidney disease education.

Narva A.

Clin J Am Soc Nephrol. 2007 Nov;2(6):1352-4. Epub 2007 Oct 10. No abstract available.

47.

Kidney disease among the Zuni Indians: the Zuni Kidney Project.

Scavini M, Shah VO, Stidley CA, Tentori F, Paine SS, Harford AM, Narva AS, Kessler DS, Bobelu A, Albert CP, Bobelu J, Jamon E, Natachu K, Neha D, Welty TK, MacCluer JW, Zager PG.

Kidney Int Suppl. 2005 Aug;(97):S126-31.

48.

End-stage renal disease due to diabetes among southwestern American Indians, 1990-2001.

Burrows NR, Narva AS, Geiss LS, Engelgau MM, Acton KJ.

Diabetes Care. 2005 May;28(5):1041-4.

PMID:
15855564
49.

Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.

Dong FB, Sorensen SW, Manninen DL, Thompson TJ, Narayan V, Orians CE, Gregg EW, Eastman RC, Dasbach EJ, Herman WH, Newman JM, Narva AS, Ballard DJ, Engelgau MM.

Pharmacoeconomics. 2004;22(15):1015-27.

PMID:
15449965
50.

Access to renal transplantation among American Indians and Hispanics.

Sequist TD, Narva AS, Stiles SK, Karp SK, Cass A, Ayanian JZ.

Am J Kidney Dis. 2004 Aug;44(2):344-52.

PMID:
15264194

Supplemental Content

Support Center